Area of research
Pathology and Forensic Medicine · Pulmonary and Respiratory Medicine
Research interest
Research focused on Lymphoma and Anaplastic large-cell lymphoma, with related work in Lymphoblastic lymphoma, Rhabdomyosarcoma, Cancer research. Notable publications include 'Revised International Pediatric Non-Hodgkin Lymphoma Staging System', 'Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial', and 'Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma'.
Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial
Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma
Revised International Pediatric Non-Hodgkin Lymphoma Staging System
Ultrasound detection of pneumonia in febrile children with respiratory distress: a prospective study
Long‐term results of the AIEOP LNH‐97 protocol for childhood lymphoblastic lymphoma
MicroRNA-27a Contributes to Rhabdomyosarcoma Cell Proliferation by Suppressing RARA and RXRA
microRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas
Epithelioid Rhabdomyosarcoma
Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK–positive anaplastic large-cell lymphoma
Children and adolescents with follicular lymphoma have an excellent prognosis with either limited chemotherapy or with a “watch and wait” strategy after complete resection
Plasma Cell-Free DNA in Paediatric Lymphomas
Central nervous system involvement in anaplastic large cell lymphoma in childhood: Results from a multicentre European and Japanese study
Monoallelic Mutations of the Perforin Gene may Represent a Predisposing Factor to Childhood Anaplastic Large Cell Lymphoma
Results of AIEOP LNH‐97 protocol for the treatment of anaplastic large cell lymphoma of childhood